Olympus to launch single-use hemostasis clip in US, with plans for global expansion

Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...

March 5, 2025 | Wednesday | News
Callio Therapeutics launches with $187 M Series A round to advance multi-payload ADC platform

Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...

March 4, 2025 | Tuesday | News
How Degrader-Antibody Conjugates Are Transforming Precision Medicine for Oncology & Beyond

Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...

March 1, 2025 | Saturday | Opinion
“Personalised medicine is now a reality, not just an aspiration”

Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...

March 1, 2025 | Saturday | Opinion
Trump’s Executive Order Impinges WHO Ops

Soon after being sworn in as the 47th President of the United States, Donald Trump signed an Executive Order to withdraw...

March 1, 2025 | Saturday | Analysis
Simbec-Orion and Avance Clinical Forge Strategic Partnership to Expand Global CRO Capabilities

This formal agreement establishes a collaborative framework between two like-minded, full-service Contract Res...

February 26, 2025 | Wednesday | News
Bristol Myers Squibb Caps 2024 with Strong Q4 Growth, Bolstered by Key Products and Pipeline Advances

“We made good progress in 2024, which was capped by a fourth quarter of strong topline growth driven by key produc...

February 26, 2025 | Wednesday | Analysis
Amgen’s 2024 Revenue Soars 19% Amid Strong Product Sales and Strategic Investments

"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...

February 26, 2025 | Wednesday | Company results
HBM Alpha Therapeutics inks deal worth $395 M to advance novel endocrine therapies

US-based startup HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by China-based Harb...

February 26, 2025 | Wednesday | News
Medtronic earns US FDA approval for world's first adaptive deep brain stimulation system for Parkinson's

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc, a global leader ...

February 25, 2025 | Tuesday | News
Andelyn Biosciences Strengthens Gene Therapy Innovation with Expanded AAV Curator™ Platform

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

February 21, 2025 | Friday | News
Parse Biosciences launches high resolution kit for single cell sequencing

US-based Parse Biosciences, the leader in high-throughput single cell sequencing, has announced the launch of Evercode W...

February 20, 2025 | Thursday | News
Merck KGaA, Darmstadt, Germany, Elevates Leadership for a Future of Innovation and Growth

"This transition is a testament to our commitment to both continuity and innovation," announced Merck KGaA, Darmstadt, G...

February 19, 2025 | Wednesday | News
Japan's NEC invests in Aetion, US-based provider of healthcare analytics platforms

NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a ...

February 19, 2025 | Wednesday | News
Pfizer Reports Strong Q4 2024 with $17.8B Revenue, Driven by Oncology and Cardiovascular Growth

Pfizer reported a strong fourth quarter (Q4) of 2024, achieving $17.8 billion in total revenues, reflecting a 21% year-o...

February 17, 2025 | Monday | Company results
Novartis Reports Strong Q4 2024 with 16% Sales Growth, Driven by Cardiovascular, Oncology, and Immunology Therapies

Novartis delivered a strong Q4 2024 performance, with net sales growing by 16% year-over-year (YoY) at constant currency...

February 17, 2025 | Monday | Company results
Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion

Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...

February 17, 2025 | Monday | Company results
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines

GSK delivered a strong performance in Q4 2024, with total sales reaching £8.12 billion, reflecting a 4% year-over-...

February 17, 2025 | Monday | Company results